title: Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection.
abstract: OBJECTIVE
  To evaluate the decay rate of cell-associated HIV-1 RNA and DNA and to identify factors associated with residual viral load in patients treated at the time of primary HIV-1 infection.
  
  
  METHODS
  A group of 15 patients adherent to highly active antiretroviral therapy (HAART) with sustained undetectable HIV-1 viremia for at least 24 months.
  
  
  METHODS
  Viremia, cell-associated HIV-1 RNA and DNA in blood and lymph node mononuclear cells were measured using ultrasensitive assays.
  
  
  RESULTS
  Viremia decreased rapidly in all patients; HIV RNA remained < 3 copies/ml in nine patients and fluctuated between 3 and 50 copies/ml in five patients and between 50 and 200 copies/ml in one patient. Decay rates of cell-associated RNA and DNA presented an inflexion point at 1 and 3 months, respectively: first-phase mean half-lives were 0.15 and 0.84 months, respectively, and second-phase mean half-lives were 13.7 and 6.6 months, respectively (95% confidence interval 4.4-13.8). The second phase decay rates were markedly slower, with a DNA decay rate that was highly associated with the mean levels of cell-associated RNA measured in blood from 6 to 33 months (P= 0.001) and in lymph nodes collected at 14 months (P= 0.02).
  
  
  CONCLUSIONS
  The clearance of HIV-1 infected cells is correlated with the extent of viral replication as measured by cell-associated RNA levels in both blood and lymph nodes. Quantification of cell-associated RNA and DNA further defines treatment efficacy in 'aviremic' patients.
authors.affiliation: Laboratory of Virology, Geneva University Hospital, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Yerly
authors.forename: T V
authors.initials: TV
authors.lastname: Perneger
authors.forename: S
authors.initials: S
authors.lastname: Vora
authors.forename: B
authors.initials: B
authors.lastname: Hirschel
authors.forename: L
authors.initials: L
authors.lastname: Perrin
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D004279:DNA, Viral / Q000032:analysis / Q000097:blood*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000821:virology; D008198:Lymph Nodes / Q000821:virology; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis / Q000097:blood; D019562:Viral Load; D014766:Viremia / Q000821:virology; D014779:Virus Replication
chemical_list: D004279:DNA, Viral; D012367:RNA, Viral